Clinical Trial Update: Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update from Novartis evaluating the safety and efficacy of Dexmethylphenidate in children with Attention-deficit/hyperactivity disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Dexmethylphenidate (dexmethylphenidate)

Snippet

Sponsor: Novartis | Conditions: ADHD | Phase 3 | Status: COMPLETED